Wei-lun Hwang

No. 250, Wuxing Street
Taipei, TNQ 11031, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Circulating N6-methyladenosine RNA as a diagnostic and a stage-associated prognostic biomarker in colorectal cancer.

Circulating N6-methyladenosine RNA as a diagnostic and a stage-associated prognostic biomarker in colorectal cancer.

Journal: BMC cancer

Published: March 16, 2026

Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatments.

Harnessing engineered mesenchymal stem cell-derived extracellular vesicles for innovative cancer treatments.

Journal: Stem cell research & therapy

Published: August 08, 2025

Inhibiting CCR3 expands cancer stem cells via c-Myc-NTSR1 axis and associates with tumor innervation features.

Inhibiting CCR3 expands cancer stem cells via c-Myc-NTSR1 axis and associates with tumor innervation features.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: August 05, 2025

Colorectal cancer stem cells develop NK cell resistance via homotypic cell-in-cell structures suppressed by Stathmin1.

Colorectal cancer stem cells develop NK cell resistance via homotypic cell-in-cell structures suppressed by Stathmin1.

Journal: Theranostics

Published: January 13, 2025

PPIH as a poor prognostic factor increases cell proliferation and m6A RNA methylation in hepatocellular carcinoma.

PPIH as a poor prognostic factor increases cell proliferation and m6A RNA methylation in hepatocellular carcinoma.

Journal: American journal of cancer research

Published: June 10, 2024

CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancer.

CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancer.

Journal: Molecular oncology

Published: November 17, 2023

Ganoderma microsporum immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells.

Ganoderma microsporum immunomodulatory protein as an extracellular epidermal growth factor receptor (EGFR) degrader for suppressing EGFR-positive lung cancer cells.

Journal: Cancer letters

Published: August 04, 2023

Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.

Haematopoietic cell-derived exosomes in cancer development and therapeutics: From basic science to clinical practice.

Journal: Clinical and translational medicine

Published: June 08, 2023

Ganoderma microsporum immunomodulatory protein combined with KRASG12C inhibitor impedes intracellular AKT/ERK network to suppress lung cancer cells with KRAS mutation.

Ganoderma microsporum immunomodulatory protein combined with KRASG12C inhibitor impedes intracellular AKT/ERK network to suppress lung cancer cells with KRAS mutation.

Journal: International journal of biological macromolecules

Published: May 17, 2023

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications.

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications.

Journal: Frontiers in immunology

Published: November 22, 2022

Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations.

Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: August 25, 2022

Characterization of Collapsin Response Mediator Protein 2 in Colorectal Cancer Progression in Subjects with Diabetic Comorbidity.

Characterization of Collapsin Response Mediator Protein 2 in Colorectal Cancer Progression in Subjects with Diabetic Comorbidity.

Journal: Cells

Published: January 12, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026